BPG is committed to discovery and dissemination of knowledge
Articles in Press
1/14/2026 5:58:10 AM | Browse: 0 | Download: 0
| Category |
Psychiatry |
| Manuscript Type |
Editorial |
| Article Title |
Investigation of the protective role of Guanxinning in antipsychotic-induced cardiac injury: Clinical implications and future directions
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Yang Cao, Peng-Fei Li, Lin Zhu, Ke Li, Xu-Dong Duan, Yu-Fei Bao, Hong-Jun Sun and Kuan-Jun He |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Natural Science Foundation of Inner Mongolia Autonomous Region |
2024LHMS08003 |
| Science and Technology Program of the Joint Fund of Scientific Research for the Public Hospitals of Inner Mongolia Academy of Medical Sciences |
2024GLLH0844 |
| Science and Technology Program of the Joint Fund of Scientific Research for the Public Hospitals of Inner Mongolia Academy of Medical Sciences |
2024GLLH0943 |
|
| Corresponding Author |
Kuan-Jun He, PhD, Professor, College of Life Sciences and Food Engineering, Inner Mongolia Minzu University, No. 996 Xilamulun Street, Tongliao 028000, Inner Mongolia Autonomous Region, China. hekuanjun@imun.edu.cn |
| Key Words |
Guanxinning; Antipsychotic drugs; Cardiac function; Protective role; Clinical implications |
| Core Tip |
Antipsychotic drug therapy carries significant cardiovascular toxicity; however, existing protective strategies remain inadequate. The traditional Chinese medicine “Guanxinning” enhances patient quality of life and safety in combination with Western medicine. This study highlights the innovative value of integrated traditional Chinese and Western medicine in addressing drug-induced cardiac toxicity, and recommends the incorporation of traditional Chinese medicine into comprehensive treatment regimens. |
| Citation |
Cao Y, Li PF, Zhu L, Li K, Duan XD, Bao YF, Sun HJ, He KJ. Investigation of the protective role of Guanxinning in antipsychotic-induced cardiac injury: Clinical implications and future directions. World J Psychiatry 2026; In press |
 |
Received |
|
2025-11-10 04:26 |
 |
Peer-Review Started |
|
2025-11-10 04:26 |
 |
First Decision by Editorial Office Director |
|
2025-11-24 11:58 |
 |
Return for Revision |
|
2025-11-24 11:58 |
 |
Revised |
|
2025-12-23 10:13 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2026-01-14 02:46 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2026-01-14 05:58 |
 |
Articles in Press |
|
2026-01-14 05:58 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
|
| ISSN |
2220-3206 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2026. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
© 2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345